Streetbeat News

Stock Prices

AURA

Aura Biosciences reported positive Phase 2 results for Bel-sar as a first-line treatment for early-stage choroidal melanoma, showing an 80% tumor control rate, 90% visual acuity preservation, and a highly favorable safety profile.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 10:33 am

CURV

Torrid Holdings announced the pricing of a public offering of 8 million shares at $4.00 per share, to be sold by certain stockholders. The offering is expected to close on September 13, 2024. Torrid will not receive any proceeds from this sale.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 10:31 am

MRNA

Moderna's stock is experiencing a decline following the company's announcement to reduce its R&D expenses by $1.1 billion by 2027.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 10:22 am

ALK

Alaska Air's shares are rising as the company has increased its Q3 adjusted EPS guidance due to better revenue and fuel cost projections.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 10:18 am

GBTC

IBIT

JPM

JPMorgan CEO Jamie Dimon, known for his past criticism of Bitcoin, has seen his stance soften as the bank now holds positions in Bitcoin-related ETFs. Despite previously calling Bitcoin a 'fraud,' JPMorgan has invested in Grayscale Bitcoin Trust and liquidated its iShares Bitcoin Trust ETF holdings.

Portfolio Pulse from Aniket Verma

September 12, 2024 | 10:11 am

MRNA

Moderna is implementing portfolio prioritization and cost efficiencies to reduce its R&D expenses by $1.1 billion, from an estimated $4.8 billion in 2024 to $3.6-$3.8 billion by 2027.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 10:06 am

USB

U.S. Bancorp has announced a share repurchase program authorizing the buyback of up to $5 billion worth of shares, with plans to start repurchasing by early 2025.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 10:02 am

BSMC

NTGR

NETGEAR, Inc. (NASDAQ:NTGR) shares are surging premarket after the company raised its Q3 2024 revenue guidance and settled a major legal dispute with TP-Link, resulting in a $135 million payment. The settlement and early launch of a new product have improved NETGEAR's financial outlook.

Portfolio Pulse from Lekha Gupta

September 12, 2024 | 10:02 am

CSBR

NTGR

RYDE

SMFL

SYRA

Champions Oncology (NASDAQ:CSBR) shares surged over 13% in pre-market trading after reporting better-than-expected Q1 earnings. Other notable pre-market movers include Smart for Life, Protagenic Therapeutics, and NETGEAR, with significant gains, while Ryde Group and Syra Health saw substantial declines.

Portfolio Pulse from Avi Kapoor

September 12, 2024 | 9:46 am

STLA

Stellantis NV (NYSE:STLA) responded to criticism from the U.S. Stellantis National Dealer Council regarding alleged 'short-term decision-making' by CEO Carlos Tavares. The company defended its strategy, citing recent sales improvements and inventory reductions. Despite a challenging first half of 2024 with a 48% drop in net profit, Stellantis plans significant investments in Michigan facilities for future growth.

Portfolio Pulse from Anan Ashraf

September 12, 2024 | 9:28 am